Regulation (EU) 2022/1644
Commission Delegated Regulation (EU) 2022/1644 of 7 July 2022 supplementing Regulation (EU) 2017/625 of the European Parliament and of the Council with specific requirements for the performance of official controls on the use of pharmacologically active substances authorised as veterinary medicinal products or as feed additives and of prohibited or unauthorised pharmacologically active substances and residues thereof (Text with EEA relevance)
In forceTyperegulationDate7 Jul 2022Since25 Dec 2022Articles4Versions held73Cited by11 documentsLast changed1 Jan 2025
- 1
- 2
- 3
- 4
- ANNEX I
- 2 ANNEX II Criteria for the selection of specific combination of substance groups and commodity groups for nat
- 3 ANNEX III Criteria for sampling strategy for national risk-based control plan for production in the Member S
- 4 ANNEX IV Criteria for the selection of specific combination of substance groups and commodity groups for nat
- 5 ANNEX V Criteria for sampling strategy for national randomised surveillance plan for production in the Membe
- 6 ANNEX VI Criteria for the selection of specific combination of substance groups and commodity groups for nat
- 7 ANNEX VII Criteria for sampling strategy for national risk-based control plan for third country imports (as
Source: EU legislation in force, consolidated versions and treaties (Cellar, Publications Office). Official publication. Reuse: Reuse authorised (Commission Decision 2011/833/EU).